Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-07

Clinical Trial Update: Hypothalamic Functional Magnetic Resonance Imaging (fMRI) Response to Nutrients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing hypothalamic fMRI responses to nutrients in obesity has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oregon Health and Science University | Conditions: Obesity | Phase 2 | Status: COMPLETED